Stay updated on ENLIVEN Trial Assessing BIO89-100 in NASH

Sign up to get notified when there's something new on the ENLIVEN Trial Assessing BIO89-100 in NASH page.
Latest website image capture
Clouds background image

Latest updates to the ENLIVEN Trial Assessing BIO89-100 in NASH page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page’s interface revision/build indicator in the footer has been updated from v3.5.2 to v3.5.3, reflecting a maintenance or release version change rather than a change to the study information.
    Difference
    0.0%
    Check dated 2026-04-25T18:35:08.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:28:29.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    Added a platform revision entry v3.5.0 and removed the previous revision v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-28T01:29:21.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the site.
    Difference
    0.0%
    Check dated 2026-03-06T18:01:58.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed Revision: v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-13T12:22:32.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1. No substantive changes to the study details, eligibility criteria, outcomes, or locations are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T09:18:07.000Z thumbnail image

Stay in the know with updates to ENLIVEN Trial Assessing BIO89-100 in NASH

Enter your email address, and we'll notify you when there's something new on the ENLIVEN Trial Assessing BIO89-100 in NASH page.